Abiopharma

News list

Casper Mark 🔴 sold 10.0K shares of Marvell Technology, Inc. (MRVL) at $135.50 ($1.4M) Transaction Date: Apr 17, 2026 | Filing ID: 026152

Full text

News bot April 21, 2026, 3:10 p.m.
🔍 Casper Mark (Executive)

Company: Marvell Technology, Inc. (MRVL)

Report Date: 2026-04-17
Transaction Summary:
- Total transactions: 2
- Derivative instruments: 0
- Holdings reported: 1
- Total shares sold: 10,000
- Total shares held: 10,263
Detailed Transactions and Holdings:
- Sold 10,000 shares of Common Stock at $135.5 per share (Direct)
  Date: 2026-04-17 | Code: S | equity_swap_involved: 0 | shares_owned_after: 35,878.00 | transaction_form_type: 4 | Footnotes: F1
- Holds 0 shares of Common Stock (Direct)
  Date: 2026-04-17 | Code: H | nature_of_ownership: By Trust | shares_owned_after: 10,263.00 | Footnotes: F2
Footnotes:
- F1: The price reported is a weighted average price. These shares were sold in multiple transactions at $135.00 and $136.00. The reporting person undertakes to provide Marvell Technology, Inc. ("Marvell"), any security holder of Marvell, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the range set forth in this footnote to this Form 4.
- F2: Held in the Mark J. Casper and Stephanie Casper Revocable Trust, of which the Reporting Person is the trustee, for the benefit of members of his immediate family.